Us2.ai

What they do

Us2.ai offers an FDA-cleared software platform that automates the analysis of 2D echocardiograms. The software provides precise, automated measurements of cardiac structure and function in minutes, reducing variability and workflow strain for sonographers and cardiologists.

The record

Vertical

Cardiovascular

Sub-segment

Echocardiography AI

Product type

Software as a medical device

Stage

Series B

Headquarters

Singapore, Singapore

Region

Asia-Pacific

Founded

2017

Total funding

$15M raised

Notable investors: Iraqi Ventures, Sequoia Capital India, Heal Partners, Tempus Partners.